| scholarly article | Q13442814 |
| P50 | author | Atsushi Nakajima | Q87641325 |
| Cyrielle Caussy | Q88372700 | ||
| P2093 | author name string | Jun Chen | |
| Xin Tu | |||
| Richard L Ehman | |||
| Rohit Loomba | |||
| Meng Yin | |||
| Siddharth Singh | |||
| Claude B Sirlin | |||
| Jonathan Hooker | |||
| Kento Imajo | |||
| Ricki Bettencourt | |||
| Kellee Kaulback | |||
| Cynthia Hsu | |||
| Minh-Da Le | |||
| P2860 | cites work | Magnetic resonance elastography of liver: technique, analysis, and clinical applications | Q27027849 |
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860537 | ||
| Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach | Q29614698 | ||
| Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis | Q30238749 | ||
| Diagnostic Performance of MR Elastography and Vibration-controlled Transient Elastography in the Detection of Hepatic Fibrosis in Patients with Severe to Morbid Obesity. | Q30357814 | ||
| Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. | Q30389544 | ||
| Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations | Q30395051 | ||
| Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study | Q30418856 | ||
| Meta-analysis of individual participant data: rationale, conduct, and reporting | Q33530020 | ||
| Liver biopsy | Q33932981 | ||
| Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection | Q34154927 | ||
| Cost-effectiveness of ultrasound-guided liver biopsy | Q34467539 | ||
| Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. | Q34544284 | ||
| Performance of transient elastography for the staging of liver fibrosis: a meta-analysis | Q34590187 | ||
| Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease | Q35893923 | ||
| Management of chronic hepatitis C: clinical audit of biopsy based management algorithm | Q36245972 | ||
| Non-invasive evaluation of liver fibrosis using transient elastography | Q37107626 | ||
| Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis | Q37581357 | ||
| Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis | Q37978790 | ||
| Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies | Q38207382 | ||
| Magnetic resonance elastography of liver. | Q38236348 | ||
| Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. | Q38680300 | ||
| American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases | Q39262015 | ||
| Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease | Q40444861 | ||
| Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. | Q41042091 | ||
| Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up | Q42201783 | ||
| The global NAFLD epidemic | Q44238213 | ||
| Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease | Q45066338 | ||
| Magnetic resonance elastography for the noninvasive staging of liver fibrosis. | Q46601756 | ||
| Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement | Q49990541 | ||
| Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver Disease | Q50148381 | ||
| Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients | Q57735452 | ||
| Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease | Q82648058 | ||
| Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan® | Q82980218 | ||
| Liver biopsy | Q83395480 | ||
| Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease | Q87406034 | ||
| P433 | issue | 4 | |
| P921 | main subject | liver disease | Q929737 |
| systematic review | Q1504425 | ||
| metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
| fatty liver disease | Q6058862 | ||
| P304 | page(s) | 630-637.e8 | |
| P577 | publication date | 2018-06-14 | |
| P1433 | published in | Clinical Gastroenterology and Hepatology | Q5133759 |
| P1476 | title | Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants | |
| P478 | volume | 17 |
| Q64104335 | A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease |
| Q90297424 | Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease |
| Q92289897 | Collagen Formation Assessed by N-Terminal Propeptide of Type 3 Procollagen Is a Heritable Trait and Is Associated With Liver Fibrosis Assessed by Magnetic Resonance Elastography |
| Q60910136 | Current status, problems, and perspectives of non-alcoholic fatty liver disease research |
| Q90185187 | Diagnostic accuracy of combined biomarker measurements and vibration-controlled transient elastography (VCTE) for predicting fibrosis stage of non-alcoholic fatty liver disease |
| Q96231800 | Discordant pathological diagnosis of non-alcoholic fatty liver disease: A prospective multicenter study |
| Q104283794 | Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population-Based Study of Mexican Americans |
| Q89506402 | Epidemiological feature of NAFLD from 1999 to 2018 in China |
| Q61796245 | Evolving role of magnetic resonance techniques in primary sclerosing cholangitis |
| Q89968285 | Limitations of non-invasive tests for assessment of liver fibrosis |
| Q90234092 | MRI Assessment of Treatment Response in HIV-associated NAFLD: A Randomized Trial of a Stearoyl-Coenzyme-A-Desaturase-1 Inhibitor (ARRIVE Trial) |
| Q91605715 | Magnetic resonance elastography in staging liver fibrosis in non-alcoholic fatty liver disease: a pooled analysis of the diagnostic accuracy |
| Q100994722 | Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis |
| Q91824073 | Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis |
| Q64254410 | Population Management of Nonalcoholic Fatty Liver Disease |
Search more.